eli lilly retatrutide Lilly's cuts weight by 17% in diabetes trial New Eli Lilly Drug Retatrutide
Description
We and others have shown that GLP-1 drugs reduce risks of many substance use and addiction disorders.
Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
BCBS Michigan cites concerns about safety, effectiveness, and cost for this decision
This review summarises current understanding of GLP-1RA-induced mitochondrial regulation in the central nervous system
Widespread access to GLP-1 therapies could generate significant benefits to society and produce huge savings for Medicare, Schaeffer research shows
SafInside patented saffron extract, titrated at 2% safranal and 3% crocins
